Assertion: primary endpoint | /r/CapableOf | capture superior protection
Facets:
value: against cin
type: OTHER
value: accurately
type: MANNER
Source sentences:
text: This new primary endpoint is a better representation of clinical benefit to accurately capture superior protection against CIN, compared with G-CSF monotherapy, which is the current standard of care,” said Dr. Douglas Blayney, global principal investigator for BeyondSpring’s Plinabulin CIN studies and Professor of Medicine at Stanford Medical School.